NCT04339478 Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy with Central Lymph Node Compartment Dissection Status COMPLETED Phase N/A
NCT04309136 Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer Status UNKNOWN Phase PHASE2
NCT04290663 Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up Status RECRUITING Phase PHASE3
NCT04285476 Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type Status ACTIVE_NOT_RECRUITING Phase NA
NCT04281875 Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. Status COMPLETED Phase NA
NCT04274829 Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid Status COMPLETED Phase N/A
NCT04238624 Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04234113 Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT04224792 Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors Status WITHDRAWN Phase NA
NCT04141306 Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality Status UNKNOWN Phase N/A
NCT04119024 Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT04104529 Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department Status RECRUITING Phase NA
NCT04072731 SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer Status COMPLETED Phase N/A